{"organizations": [], "uuid": "64e5b44a1386cb440dcaf13d956d1af47ed6c23f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pixium-vision-gets-fda-approval-fo/brief-pixium-vision-gets-fda-approval-for-human-clinical-study-of-prima-sub-retinal-implant-idUSASM000HPT", "country": "US", "domain_rank": 408, "title": "BRIEF-Pixium Vision Gets FDA Approval For Human Clinical Study Of Prima Sub-Retinal Implant", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-04T08:06:00.000+02:00", "replies_count": 0, "uuid": "64e5b44a1386cb440dcaf13d956d1af47ed6c23f"}, "author": "", "url": "https://www.reuters.com/article/brief-pixium-vision-gets-fda-approval-fo/brief-pixium-vision-gets-fda-approval-for-human-clinical-study-of-prima-sub-retinal-implant-idUSASM000HPT", "ord_in_thread": 0, "title": "BRIEF-Pixium Vision Gets FDA Approval For Human Clinical Study Of Prima Sub-Retinal Implant", "locations": [], "entities": {"persons": [], "locations": [{"name": "us", "sentiment": "none"}], "organizations": [{"name": "fda approval for human clinical study of prima", "sentiment": "negative"}, {"name": "fda approval for human clinical study of prima sub-retinal implant", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "macular", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 4 (Reuters) - PIXIUM VISION SA:\n* PIXIUM VISION RECEIVES FDA APPROVAL TO BEGIN HUMAN CLINICAL STUDY OF ITS PRIMA SUB-RETINAL IMPLANT IN THE US\n* RECEIVES FDA APPROVAL TO BEGIN HUMAN CLINICAL STUDY OF ITS PRIMA SUB-RETINAL IMPLANT IN US\n* FEASIBILITY CLINICAL STUDY IS DESIGNED TO EVALUATE PRIMA IN PATIENTS WITH ATROPHIC DRY AGE-RELATED MACULAR DEGENERATION\n* EXPECTS TO START US STUDY IN FIRST HALF OF 2018. Source text for Eikon: Further company coverage: (Gdynia Newsroom:)\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": [], "published": "2018-01-04T08:06:00.000+02:00", "crawled": "2018-01-04T08:11:37.012+02:00", "highlightTitle": ""}